Related Experiment Video
Updated: Jun 6, 2026

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
Published on: August 30, 2020
Cardiac damage after subarachnoid hemorrhage
Bihua Wu1, Xiaoming Wang, John H Zhang
1Department of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637007, People's Republic of China. wubihua2008@yahoo.com
Insights
Subarachnoid hemorrhage (SAH) can cause cardiac complications like T-wave inversion and QT interval prolongation, even in patients without prior heart disease. Further research is needed to support treatments like beta-blockers for these neurocardiogenic injuries.
Area of Science:
- Neurology
- Cardiology
- Genetics
Background:
- Subarachnoid hemorrhage (SAH) is known to cause cardiac complications.
- Electrocardiogram (ECG) abnormalities like T-wave inversion and QT prolongation occur in patients post-SAH, irrespective of pre-existing cardiac conditions.
- These cardiac issues are forms of neurocardiogenic injury.
Purpose of the Study:
- To summarize the cardiac complications following SAH.
- To discuss the modulating factors of SAH's autonomic and cardiovascular effects.
- To review the evidence for therapeutic interventions like beta-blockers.
Main Methods:
- Literature review of studies on SAH and cardiac complications.
- Analysis of ECG findings and myocardial damage markers post-SAH.
- Evaluation of clinical trial data for interventions.
Main Results:
- SAH frequently leads to cardiac injury, including ECG changes, arrhythmias, and myocardial damage.
- Concomitant factors such as pre-existing heart disease, electrolyte imbalances, and genetic factors influence SAH's cardiovascular impact.
- Clinical trials supporting beta-blocker use for SAH-induced myocardial damage are lacking.
Conclusions:
- Cardiac complications are a significant concern after SAH.
- The interplay between neurological and cardiovascular systems in SAH is complex and influenced by multiple factors.
- Current evidence does not support the routine use of beta-blockers for acute cerebrovascular disease management post-SAH.
Abstract:
Patients who had no heart disease had T-wave inversion and prolongation of the QT interval in electrocardiogram after Subarachnoid hemorrhage (SAH), which was reported 70years before. Cardiac complications, including focal myocytolysis, electrocardiographic changes, arrhythmias and left ventricular wall motion abnormalities and pulmonary edema. The autonomic and cardiovascular effects of SAH, however, are modulated by concomitant factors such as pre-existent cardiac diseases, electrolyte disorders and, probably, by genetic alterations in the ionic control of myocyte repolarization. Although beta-blockers have been reported to prevent myocardial damage following SAH, adequate clinical trials are lacking, and the widespread use of these drugs in acute cerebrovascular disease is not supported by evidence. Cardiac injury occurs frequently after SAH, and the most widely investigated form of neurocardiogenic injury.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Secondary Spinal Cord Injury llI: Pathophysiology
Stroke: Introduction and Types
Ischemic Stroke ll: Pathophysiology
Increased Intracranial Pressure ll: Pathophysiology
